Enabling next-generation analysis of rare cells with an open and end-to-end platform that supports clinical trials worldwide

News & Events

Meet the RareCyte® team at Molecular Tri-Con Molecular Med TRI-CON
March 10-15, 2019
San Francisco, CA
Booth #701
more →

RareCyte introduces the CyteFinder HT instrument at AACR for high capacity slide-based imaging optimized for liquid biopsy

more →

Highlight

CTC Clinical Research

RareCyte enables practical deployment of CTC-based liquid biopsy with instrumentation and consumables that provide an exquisitely sensitive, accurate, reproducible, and transparent workflow from blood collection to single cell isolation.

more →

Pharma Programs

RareCyte Pharma Programs support pharma development through our expert product development teams. Our services span the range from RUO product development for pre-clinical and clinical research to IVD support for companion diagnostic co-development.

more →